Acute Myelocytic Leukemia

Search Trials
A Safety Study of SGN-CD123A in Patients With Acute Myeloid Leukemia
Status:
Terminated
Last Changed:
May 14, 2018
First Changed:
Jul 28, 2016
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
SGN-CD123A
Clofarabine Salvage Therapy in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Status:
Completed
Last Changed:
Oct 7, 2015
First Changed:
Feb 14, 2011
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
Clofarabine
IMGN632 as Monotherapy or With Venetoclax and/or Azacitidine for Patients With CD123-Positive Acute Myeloid Leukemia
Status:
Recruiting
Last Changed:
May 27, 2021
First Changed:
Sep 11, 2019
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
AzacitidineIMGN632Venetoclax
A Study of Oral Venetoclax Tablet in Combination With Subcutaneous Low-Dose Cytarabine (LDAC) Injection to Assess Adverse Events in Adult Japanese Participants With Acute Myeloid Leukemia (AML)
Status:
Completed
Last Changed:
May 12, 2021
First Changed:
Aug 12, 2020
Disease(s):
Acute Myeloid Leukemia (AML)
Intervention(s):
VenetoclaxCytarabine
Sabatolimab as a Treatment for Patients With Acute Myeloid Leukemia and Presence of Measurable Residual Disease After Allogeneic Stem Cell Transplantation.
Status:
Recruiting
Last Changed:
Oct 8, 2021
First Changed:
Nov 10, 2020
Disease(s):
Acute Myeloid Leukemia
Intervention(s):
SabatolimabAzacitidine

Connect. Empower. Inspire.